^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

IMMU-140

i
Other names: IMMU-140, IMMU 140, anti-HLA-DR-SN-38 ADC, hL243-CL2A-SN-38
News
Trials
Company:
Gilead
Drug class:
Topoisomerase I inhibitor, HLA-DR-targeted antibody-drug conjugate
Related drugs:
News
Trials